| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | -90.0% |
| Cost of Revenue | $263K | -91.9% |
| R&D Expense | $216K | -95.6% |
| SG&A Expense | $5.7M | +39.5% |
| Operating Income | -$5.1M | -147.4% |
| Pre-tax Income | -$4.4M | -305.1% |
| Income Tax | -$138K | -579.4% |
| Net Income | -$8.4M | -689.5% |
| EPS (Basic) | -$0.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.6M | -22.0% |
| Current Assets | $11.2M | -23.9% |
| Total Assets | $15.9M | -33.6% |
| Current Liabilities | $3.5M | +12.9% |
| Total Liabilities | $4.0M | +5.9% |
| Stockholders' Equity | $11.9M | -40.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -179.6% |
| Investing Cash Flow | -$85K | +0.0% |
| Financing Cash Flow | $40K | +651.4% |
| -658.3% |
| EPS (Diluted) | -$0.91 | -658.3% |